OJC closes the year with 19% annual sales growth

Today our small cap FMCG Investment, The Original Juice Company (ASX:OJC), published its annual financial report to shareholders.

Key highlights include 67% EBITDA growth from last year (up to $1.23M) and 19% growth in gross sales from last year (up to $53M):

(Source)

This strong growth in sales revenue is validation that the OJC model is working, and proof that its products are resonating with consumers in Australia.

OJC is a beverage manufacturing company that sells premium fruit juices and probiotic wellness shots in major supermarkets Coles and Woolworths.

The company is working on a Fix → Reset → Growth model.

It is one thing to say that the company will reset its balance sheet and grow, and it is another thing to actually execute on this strategy.

We think that the results from this annual report show that OJC is on the right track with growth in EBITDA and Gross Sales.

We look forward to what the next 12 months will bring for OJC as the company looks to improve upon what looks like a strong year in FY22/23.

What is next for OJC?

In May this year OJC signed a deal with Aldi China. The first shipment of juice is expected this quarter.

We are looking forward to seeing how this relationship will translate to sales, and if OJC’s products can resonate with the Chinese market.

Read our full take: OJC enters Chinese Market with Aldi

We are also anticipating further growth opportunities for OJC and potential domestic distribution deals to get its products in the hands of more Australian consumers.